DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR IMIPENEM AND CILASTATIN

« Back to Dashboard

All Clinical Trials for Imipenem And Cilastatin

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00080496	Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia	Completed	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3	2003-07-01	To compare the efficacy and safety of the tigecycline regimen with that of the imipenem/cilastatin regimen in subjects with nosocomial pneumonia.
NCT00081744	Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects	Completed	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3	2002-11-01	Purpose: To provide a mechanism for the emergency use of tigecycline in the appropriate clinical situations.
NCT00136201	Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections	Completed	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3	2005-11-01	The primary objective of this study is to compare the safety and efficacy of an experimental antibiotic to a marketed antibiotic in the treatment of Chinese subjects with complicated intra-abdominal infections.

Clinical Trial Conditions for Imipenem And Cilastatin

Condition Name

Condition Name for Imipenem And Cilastatin
Intervention	Trials
Urinary Tract Infections	3
Complicated Urinary Tract Infection	2
Suspected or Documented Gram-negative Bacterial Infection	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Imipenem And Cilastatin
Intervention	Trials
Infection	17
Communicable Diseases	15
Pneumonia	7

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Imipenem And Cilastatin

Trials by Country

Trials by Country for Imipenem And Cilastatin
Location	Trials
United States	49
China	29
Argentina	6
Brazil	6
Canada	6

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Imipenem And Cilastatin
Location	Trials
California	4
Ohio	4
Illinois	3
North Carolina	2
Maryland	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Imipenem And Cilastatin

Clinical Trial Phase

Clinical Trial Phase for Imipenem And Cilastatin
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	12
Phase 2/Phase 3	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Imipenem And Cilastatin
Clinical Trial Phase	Trials
Completed	12
Recruiting	8
Not yet recruiting	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Imipenem And Cilastatin

Sponsor Name

Sponsor Name for Imipenem And Cilastatin
Sponsor	Trials
Merck Sharp & Dohme Corp.	11
Wyeth is now a wholly owned subsidiary of Pfizer	3
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	3

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Imipenem And Cilastatin
Sponsor	Trials
Industry	26
Other	11

Export unavailable in trial.
Subscribe for complete access.